Cervical cancer immunotherapy: facts and hopes
It is a sad fact that despite being almost completely preventable through human
papillomavirus (HPV) vaccination and screening, cervical cancer remains the fourth most …
papillomavirus (HPV) vaccination and screening, cervical cancer remains the fourth most …
Therapeutic vaccines for HPV-associated malignancies
C Smalley Rumfield, N Roller, ST Pellom… - ImmunoTargets and …, 2020 - Taylor & Francis
Human papillomavirus (HPV)-related malignancies are responsible for almost all cases of
cervical cancer in women, and over 50% of all cases of head and neck carcinoma …
cervical cancer in women, and over 50% of all cases of head and neck carcinoma …
Perspectives for therapeutic HPV vaccine development
Background Human papillomavirus (HPV) infections and associated diseases remain a
serious burden worldwide. It is now clear that HPV serves as the etiological factor and …
serious burden worldwide. It is now clear that HPV serves as the etiological factor and …
Immunologic treatments for precancerous lesions and uterine cervical cancer
P Vici, L Mariani, L Pizzuti, D Sergi, L Di Lauro… - Journal of Experimental …, 2014 - Springer
Abstract Development of HPV-associated cancers not only depends on efficient negative
regulation of cell cycle control that supports the accumulation of genetic damage, but also …
regulation of cell cycle control that supports the accumulation of genetic damage, but also …
Current and future direction in treatment of HPV-related cervical disease
N Khairkhah, A Bolhassani, R Najafipour - Journal of Molecular Medicine, 2022 - Springer
Human papillomavirus (HPV) is the most common sexually transmitted virus in the world.
About 70% of cervical cancers are caused by the most oncogenic HPV genotypes of 16 and …
About 70% of cervical cancers are caused by the most oncogenic HPV genotypes of 16 and …
Display of recombinant proteins at the surface of lactic acid bacteria: strategies and applications
C Michon, P Langella, VGH Eijsink, G Mathiesen… - Microbial cell …, 2016 - Springer
Lactic acid bacteria (LAB) are promising vectors of choice to deliver active molecules to
mucosal tissues. They are recognized as safe by the World Health Organization and some …
mucosal tissues. They are recognized as safe by the World Health Organization and some …
Does Lactobacillus Exert a Protective Effect on the Development of Cervical and Endometrial Cancer in Women?
K Frąszczak, B Barczyński, A Kondracka - Cancers, 2022 - mdpi.com
Simple Summary Cervical cancer is the fourth most common cancer in women worldwide.
Tumour-related deaths are most frequent in low-and middle-income countries. Currently …
Tumour-related deaths are most frequent in low-and middle-income countries. Currently …
Current state in the development of candidate therapeutic HPV vaccines
A Yang, J Jeang, K Cheng, T Cheng… - Expert review of …, 2016 - Taylor & Francis
The identification of human papillomavirus (HPV) as an etiological factor for HPV-associated
malignancies creates the opportunity to control these cancers through vaccination …
malignancies creates the opportunity to control these cancers through vaccination …
Role of Lactobacillus in cervical cancer
X Yang, M Da, W Zhang, Q Qi, C Zhang… - Cancer management …, 2018 - Taylor & Francis
Cervical cancer is a common malignant cancer among women worldwide. Changes in the
vaginal microecological environment lead to multiple gynecological diseases, including …
vaginal microecological environment lead to multiple gynecological diseases, including …
Oral vaccination against HPV E7 for treatment of cervical intraepithelial neoplasia grade 3 (CIN3) elicits E7-specific mucosal immunity in the cervix of CIN3 patients
K Kawana, K Adachi, S Kojima, A Taguchi, K Tomio… - Vaccine, 2014 - Elsevier
Background Cervical intraepithelial neoplasia grade 3 (CIN3) is a mucosal precancerous
lesion caused by high-risk human papillomavirus (HPV). Induction of immunological …
lesion caused by high-risk human papillomavirus (HPV). Induction of immunological …